Asthma Therapeutics Flashcards
Define self-management in asthma
What the patient does to manage their own chronic disease
- NOT what the health clinician does
What are the overall asthma goals of therapy? (7)
- maintain control of daytime symptoms
- maintain control of night-time symptoms
- Maintain normal activity and exercise levels
- Maintain normal spirometry values
- Prevent asthma exacerbations
- Provide optimal drug therapy while avoiding use of reliever inhaler
- less than 2x/week - Prevent asthma mortality
Is it possible for every patient to achieve all the asthma goals?
No, patients who have more severe sx may not achieve all of this
What are the 5 steps for a patient to become a good self-manager of asthma (i.e developing a partnership with a patient)
- Provide asthma education
- Setting asthma goals of therapy
- Self-monitory of their asthma (green, yellow, red zone) (asthma diary form)
- Asthma review
- Create an asthma action plan
What should you review with a patient about their asthma? (3)
- Asthma control
- Adherence to plan
- Inhaler technique
What are key features of an asthma action plan (6)
- Doses and frequencies of daily meds
- when and how to use reliever + controller meds - How to adjust meds at home in response to symptoms
- Listing patients PEF levels
- Symptoms when they need to seek emergency medical care
- Emergency phone #s
- A list of triggers
What is the MOA of the specific allergen immunotherapy? is it efficacious?
Give patients weekly injections of allergens to improve tolerance
MOA
- immune modification of T-lymphocytes away from Th2 inflammation (driver of allergic inflammation
Modest efficacy
Does flu vaccine protect asthma exacerbation and improve asthma control?
No
What are 2 features of a treatment plan for asthma patients
- Asthma control
- not just symptom control, but QOL - Risk for exacerbations
What is considered a well-controlled asthma patient in the following characteristics:
Daytime sx
Nighttime sx
Physical activity
Exacerbations
Absence from school or work
Need for a reliever
FEV1 or PEF
PEF dirunal variation
Daytime sx: 2x/week or less
Nighttime sx: None
Physical activity: Normal
Exacerbations: mild and infrequent (not affecting qol)
Absence from school or work: None
Need for a reliever: 2x/week or less
FEV1 or PEF: 90% of personal best
PEF dirunal variation: less than 10-15%
Do individuals who have well-controlled asthma/mild asthma still have risk of exacerbation
Yes
Define an asthma exacerbation
Episode of progressively increasing SOB, cough, wheeze, chest tightness, which is potentially life threatening
- see MD or ER
**Watch out for poor perceivers
Which values do they monitor in the ER during an exacerbation? (2)
What is the treatment? What shouldn’t you do?
Monitor:
- FEV1 or PEF
- O2 saturation (90%+ adult, 95%+ children)
- cardiac function
Treatment
1. O2 and hydration
2. SABA (pMDI + spacer) continuously for the 1st hour
- if not better? SABA + anticholinergic
3. May use systemic corticosteroids
NO SEDATION
What are the 3 classes of reliever medications?
- SABA
- LABA
- Anticholinergic inhaler
What are the 3 SABA inhalers
- Salbutamol
- Terbutaline
- Formoterol
What are the 2 LABA inhalers (specific criteria) Age?
- Formoterol + budesonide: symbicort
- can be used as a reliever + controller - Salmeterol + fluticasone: advair
- CAN’T be used as a reliever (controller)
All 12+
What is the anticholinergic inhaler? age?
Ipratropium bromide (atrovent)
18+
Class, Onset, duration, type of therapy (reliever/controller/both)
Salbutamol
Salmeterol
Formoterol
Salbutamol
Class: SABA
Onset: 3-5 min
Duration: 4-6h
Type: Reliever
Salmeterol
Class: LABA
Onset: 30-50 min
Duration: 12hr
Type: Controller
Formoterol
Class: SABA/LABA
Onset: 3-5 min
Duration: 12 hour
Type: Reliever and controller ONLY in combo tho
What is the MOA of SABA and safety profile?
MOA
Activate B2 receptors on mast cells to reduce mast cell degranulation and prevent release of inflammatory mediators
- relax bronchiole smooth muscle
- Dec. vascular leakage
- Improve mucous transport out of airways
Safety
- low usage: safe
- high usage: lose selectivity of B2, targets B1 (heart) + B2 –> tremor, palpitations, tachycardia
What is the indication (3) of anticholinergic (ipratropium bromide)? Efficacy?
Indication (add-on)
- Pt with asthma exacerbations in hospital
- If has both asthma and COPD
- Intolerant of SABA side effects
Efficacy
- less potent, less effective, slower onset than SABA’s
- poorly absorbed
What is the MOA and safety (side effects) of anticholinergics?
MOA
Inhibits ACh binding to muscarinic receptors in airways
- relax bronchiole smooth muscle
- Dec. vascular leakage
- Improve mucous transport out of airways
Safety
- dry mouth, bitter test
- urinary retention
- ocular effects (eye pain, blurred vision, redness)
What is the MOA of ICS?
MOA
- Prevents formation of PG’s, leukotrienes, chemical modulators, transcription factors that produce inflammatory cytokines
- Alters synthesis of mRNA when interacted with glucocorticoid receptor
ICS Onset: initial improvement, max improvement
Symptoms
FEV1
BHR (hyper-responsiveness)
Symptoms
- Initial: 1-2 weeks
- Max: 4-8 weeks
FEV1
- Initial: 1-2 weeks
- Max: 3-6 weeks
BHR (hyper-responsiveness)
- Initial: 2-3 weeks
- Max: 1year+